Literature DB >> 28743576

A review on protein misfolding, aggregation and strategies to prevent related ailments.

Tooba Naz Shamsi1, Teeba Athar2, Romana Parveen3, Sadaf Fatima4.   

Abstract

This review aims to highlight the fundamental mechanism of protein misfolding leading to protein aggregation and associated diseases. It also aims to anticipate novel therapeutic strategies with which to prevent or treat these highly debilitating conditions linked to these pathologies. The failure of a protein to correctly fold de novo or to remain correctly folded can have profound consequences on a living system especially when the cellular quality control processes fail to eliminate the rogue proteins. The core cause of over 20 different human diseases which have now been designated as 'conformational diseases' including neurodegenerative diseases such as Alzheimer's disease (AD), Huntington's disease (HD) and Parkinson's disease (PD) etc. A comprehensive study on protein misfolding, aggregation, and the outcomes of the effects of cytotoxic aggregates will lead to understand the aggregation-mediated cell toxicity and serves as a foundation for future research in development of promising therapies and drugs. This review has also shed light on the mechanism of protein misfolding which leads to its aggregation and hence the neurodegeneration. From these considerations, one could also envisage the possibility that protein aggregation may be exploited by nature to perform specific physiological functions in differing biological contexts.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Neurodegenerative diseases; Protein aggregation; Protein misfolding

Mesh:

Substances:

Year:  2017        PMID: 28743576     DOI: 10.1016/j.ijbiomac.2017.07.116

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  10 in total

1.  Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity.

Authors:  Lap Ho; Danyue Zhao; Kenjiro Ono; Kai Ruan; Ilaria Mogno; Mayumi Tsuji; Eileen Carry; Justin Brathwaite; Steven Sims; Tal Frolinger; Susan Westfall; Paolo Mazzola; Qingli Wu; Ke Hao; Thomas E Lloyd; James E Simon; Jeremiah Faith; Giulio M Pasinetti
Journal:  J Nutr Biochem       Date:  2018-11-14       Impact factor: 6.048

2.  Ligand-induced disorder-to-order transitions characterized by structural proteomics and molecular dynamics simulations.

Authors:  Karl A T Makepeace; Nicholas I Brodie; Konstantin I Popov; Geoff Gudavicius; Christopher J Nelson; Evgeniy V Petrotchenko; Nikolay V Dokholyan; Christoph H Borchers
Journal:  J Proteomics       Date:  2019-11-01       Impact factor: 4.044

3.  Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms.

Authors:  Lap Ho; Kenjiro Ono; Mayumi Tsuji; Paolo Mazzola; Risham Singh; Giulio M Pasinetti
Journal:  Expert Rev Neurother       Date:  2017-11-14       Impact factor: 4.618

Review 4.  Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges.

Authors:  Vishal Kumar; Charan Singh; Arti Singh
Journal:  Mol Biol Rep       Date:  2021-10-19       Impact factor: 2.316

5.  Probing the Role of Cu(II) Ions on Protein Aggregation Using Two Model Proteins.

Authors:  Reshmi John; Jissy Mathew; Anu Mathew; Charuvila T Aravindakumar; Usha K Aravind
Journal:  ACS Omega       Date:  2021-12-15

6.  Flavonoids as Potential Drugs for VPS13-Dependent Rare Neurodegenerative Diseases.

Authors:  Piotr Soczewka; Krzysztof Flis; Déborah Tribouillard-Tanvier; Jean-Paul di Rago; Cláudia N Santos; Regina Menezes; Joanna Kaminska; Teresa Zoladek
Journal:  Genes (Basel)       Date:  2020-07-21       Impact factor: 4.096

7.  Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnover.

Authors:  David Brooks; Fawwaz Naeem; Marta Stetsiv; Samantha C Goetting; Simranjot Bawa; Nicole Green; Cheryl Clark; Arash Bashirullah; Erika R Geisbrecht
Journal:  PLoS Genet       Date:  2020-04-22       Impact factor: 5.917

8.  Sulforaphane Upregulates Cultured Mouse Astrocytic Aquaporin-4 Expression through p38 MAPK Pathway.

Authors:  Canhong Yang; Sisi Qin; Jiafa Zhang; Yuanyuan Wang; Huan Li; Tianming Lü
Journal:  J Healthc Eng       Date:  2022-08-10       Impact factor: 3.822

Review 9.  Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease.

Authors:  Teeba Athar; K Al Balushi; Shah Alam Khan
Journal:  Mol Biol Rep       Date:  2021-06-28       Impact factor: 2.316

10.  Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization.

Authors:  Antonio Dominguez-Meijide; Eftychia Vasili; Annekatrin König; Maria-Sol Cima-Omori; Alain Ibáñez de Opakua; Andrei Leonov; Sergey Ryazanov; Markus Zweckstetter; Christian Griesinger; Tiago F Outeiro
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.